HIGH-VOLUME · HOSP-HEAVY
fenofibrate Side Effects
fenofibrate (also sold as TriCor, Antara) is HIGH-VOLUME in this FAERS book #143 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 33.4% mention hospitalization (16,065 reports).
Data updated 2026-05-15
- 48,091
- FAERS reports
FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
fenofibrate: 33.4% mention hospitalization (16,065 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #143 of 524 by FAERS report count.
High-report extract for fenofibrate (TriCor): 48,091 FAERS rows (2004-2025). Top named reactions: NAUSEA, FATIGUE, DIARRHOEA. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
NAUSEA leads 2,912 of 48,091 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (13,365 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,471 reports, 7.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,051 |
| DYSPNOEA | 355 |
| SEPSIS | 342 |
| FALL | 335 |
| DIARRHOEA | 324 |
| ASTHENIA | 315 |
| CARDIO-RESPIRATORY ARREST | 308 |
| FATIGUE | 284 |
| NAUSEA | 277 |
| DECREASED APPETITE | 266 |
| ASCITES | 265 |
| VOMITING | 256 |
| DIZZINESS | 254 |
| ABDOMINAL PAIN | 247 |
| SOMNOLENCE | 246 |
| HAEMORRHAGIC STROKE | 242 |
| ARTHRALGIA | 240 |
| TACHYCARDIA | 240 |
| RENAL FAILURE | 239 |
| ALTERED STATE OF CONSCIOUSNESS | 238 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (16,065, 33.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 972 |
| FALL | 956 |
| NAUSEA | 895 |
| ACUTE KIDNEY INJURY | 865 |
| DIARRHOEA | 855 |
| PNEUMONIA | 822 |
| FATIGUE | 792 |
| ASTHENIA | 790 |
| RENAL FAILURE | 727 |
| PAIN | 717 |
| VOMITING | 709 |
| MYOCARDIAL INFARCTION | 693 |
| DIZZINESS | 596 |
| WEIGHT DECREASED | 575 |
| CHEST PAIN | 557 |
| PYREXIA | 555 |
| DRUG INTERACTION | 533 |
| DEHYDRATION | 520 |
| ANAEMIA | 511 |
| ABDOMINAL PAIN | 509 |
How to read fenofibrate FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 48,091 voluntary reports linked to fenofibrate (TriCor, Antara), 2004-2025. Death is listed on 3,471 (7.2%). Hospitalization appears on 16,065 (33.4%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.
Read with fenofibrate
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 47,843 FAERS cases (Δ 248 lighter vs fenofibrate); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 47,788 FAERS cases (Δ 303 lighter vs fenofibrate); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 48,513 FAERS cases (Δ 422 heavier vs fenofibrate); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 47,513 FAERS cases (Δ 578 lighter vs fenofibrate); DEATH-MARKED · HOSP-LIGHT · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 54.9 pp vs fenofibrate's DEATH-HEAVY): CASELOAD · HOSP-MID.
fenofibrate stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.